GPI coverage and content

You can use Global Patent Index (GPI) to carry out detailed searches in the EPO's worldwide bibliographic (DOCDB), legal event (INPADOC) and full-text data sets, and download or visualise the search results for statistical analysis.

Current content: 159 515 718 patent documents

This week's update (01/11/2024 12:00 CET):

154 531 new documents added

1 078 520 documents amended

GPI key values

Run regular monitoring (e.g. monthly or quarterly) of technical areas or companies

Use built-in charts to visualise technical trends and patenting activity of companies

Choose the data you want to see and download to focus on what you are interested in

Run data quality assessments to measure the risk of incomplete search results

EP 1709008 A1 20061011 - SALTS OF HMG-COA REDUCTASE INHIBITORS AND USE THEREOF

Title (en)

SALTS OF HMG-COA REDUCTASE INHIBITORS AND USE THEREOF

Title (de)

SALZE VON HMG-COA-REDUKTASE-INHIBITOREN UND DEREN VERWENDUNG

Title (fr)

SELS DES INHIBITEURS DE HMG-COA REDUCTASE ET LEUR UTILISATION

Publication

EP 1709008 A1 20061011 (EN)

Application

EP 05702276 A 20050119

Priority

IB 2005000114 W 20050119
IN 78DE2004 A 20040119

Abstract (en)

[origin: WO2005077916A1] The present invention relates to salts of HMG CoA reductase inhibitors, and in particular, rosuvastatin amine salts and their use as intermediates in the preparation of rosuvastatin calcium.

IPC 8 full level

C07D 239/42 (2006.01)

CPC (source: EP)

C07D 239/42 (2013.01)

Citation (search report)

See references of WO 2005077916A1

Citation (examination)

WO 2005051921 A1 20050609 - TEVA PHARMA [IL], et al

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005077916 A1 20050825; EP 1709008 A1 20061011

DOCDB simple family (application)

IB 2005000114 W 20050119; EP 05702276 A 20050119